Compare Halliburton Company (HAL) vs Novo Nordisk A/S (NVO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halliburton Company vs Novo Nordisk A/S — how do they compare? Halliburton Company trades at $33.7 (market cap $28.16B), while Novo Nordisk A/S trades at $45.97 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 7.4× Halliburton Company's market cap, and Novo Nordisk A/S pays the higher dividend (3.81%). Which is the better fit depends on your goals.
| HAL | NVO | |
|---|---|---|
Market Cap | $28.16B | $207.85B |
Sector | Energy | Health |
52-Week High | $42.98 | $63.98 |
52-Week Low | $20.97 | $35.29 |
Enterprise Value | $34.31B | $222.55B |
Dividend Yield | 2.01% | 3.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Halliburton Company
Halliburton is one of the three largest oilfield service firms in the world, offering superior expertise in a number of business lines, including completion fluids, wireline services, cementing, and countless others. It's the number one pressure pumper in North America, and has been a leading innovator in hydraulic fracturing over the last two decades.
Read more on HAL →About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →
